Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Radiol.

Sec. Neuroradiology

Volume 5 - 2025 | doi: 10.3389/fradi.2025.1683274

This article is part of the Research TopicPrecision Neuroimaging for MRgFUS in Neurological DisordersView all 3 articles

Radiomic signatures from postprocedural MRI thalamotomy lesion can predict long-term clinical outcome in patients with tremor after MRgFUS: a pilot study

Provisionally accepted
  • 1Universita degli Studi dell'Aquila, L'Aquila, Italy
  • 2Universita degli Studi di Bologna Dipartimento di Scienze Mediche e Chirurgiche, Bologna, Italy
  • 3IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Bologna, Italy
  • 4Universita degli Studi dell'Aquila Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, L'Aquila, Italy
  • 5Ospedale Civile San Salvatore, L'Aquila, Italy

The final, formatted version of the article will be published soon.

Objective: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is an effective treatment for essential tremor (ET) and tremor-dominant Parkinson's disease (PD), yet a substantial proportion of patients experience tremor recurrence over time. Reliable imaging biomarkers to predict long-term outcomes are lacking. The purpose of the study was to evaluate whether radiomic features extracted from 24-hour post-treatment MRI can predict clinically relevant tremor recurrence at 12 months after MRgFUS thalamotomy, using a machine learning (ML) approach. Materials and Methods: Retrospective, single-center study included 120 patients (61 ET, 59 PD) treated with unilateral MRgFUS Vim thalamotomy between February 2018 and June 2023. Tremor severity was assessed using part A of the Fahn–Tolosa–Marin Tremor Rating Scale (FTM-TRS) at baseline and 12 months. Recurrence was defined as an FTM-TRS part A score ≥ 3 at 12 months. Lesions were manually segmented on 24-hour post-treatment T2-weighted MRI. Forty radiomic features (18 first-order, 22 texture GLCM from Laplacian of Gaussian–filtered images) were extracted. A linear Support Vector Classifier with leave-one-out cross-validation was used for classification. Model explainability was assessed using SHapley Additive exPlanations (SHAP). Results: Clinically relevant tremor recurrence occurred in 23 patients (19%). For the full cohort, the ML model achieved a balanced accuracy of 0.720, weighted F1-score of 0.737, and comparable sensitivity and specificity across classes. Performance was higher in PD (BA = 0.808, F1 = 0.793) than in ET (BA = 0.580, F1 = 0.696). The most predictive features were texture-derived GLCM metrics, particularly from edge-enhanced images, with first-order features contributing complementary information. No significant correlations were found between radiomic features and procedural parameters. Conclusion: Radiomic analysis of MRgFUS lesions on 24-hour post-treatment MRI can provide early prediction of 12-month tremor recurrence, with higher predictive value in PD than in ET. Texture-based features may capture microstructural characteristics linked to treatment durability. This approach could inform post-treatment monitoring and individualized management strategies.

Keywords: Essential Tremor, Parkinson's disease, MRgFUS thalamotomy, machine learning, Radiomics, MRI, Neuroimaging

Received: 10 Aug 2025; Accepted: 14 Oct 2025.

Copyright: © 2025 INNOCENZI, Peluso, Bruno, Balducci, Rocchi, Bellini, Catalucci, Sucapane, Saporito, Russo, Castellani, Pistoia and Splendiani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Federico Bruno, federico.bruno.1988@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.